Coronavirus Live Updates | Bahrain authorizes AstraZeneca’s anti-Covid drug for emergency use

India added 10,229 new coronavirus infections, taking the total number of COVID-19 cases in the country to 3,44,47,536, while active cases dropped to 1,34,096, according to data updated by the Union Health Ministry on Monday. Which is the lowest in 523 days. ,

you can track coronavirus Cases, deaths and testing rates at the national and state levels Here, List state helpline number also available.

Here are the latest updates:

Bahrain

Bahrain authorizes AstraZeneca’s anti-Covid drug for emergency use

Bahrain has approved the emergency use of AstraZeneca’s anti-COVID drug Evusheld, the state news agency reported on Sunday.

Bahrain has become the first country to authorize the drug, which will be limited to adults who suffer from immunodeficiency or who are taking immunosuppressants, as well as individuals with occupations that put them at risk of transmission, the news agency said. .

Israel

Israel says children aged 5-11 can get COVID-19 vaccine

Israel said on Sunday that children between the ages of five and 11 would be eligible for vaccination against COVID-19, and the campaign’s start date would be made public within a few days.

The decision, announced by the health ministry, follows approval by its expert panel on vaccination last week, after the US Food and Drug Administration allowed emergency use for the age group at 10-microgram doses of Pfizer and BioNTech’s vaccines.

The basic shot given to people 12 years of age and older is 30 micrograms. Pfizer and BioNTech have said that their vaccine has shown 90.7% efficacy against the coronavirus in a clinical trial in children aged five to 11 years.

The ministry said in a statement that the date for children between the ages of five and 11 to start receiving the Pfizer/BioNTech vaccine would be decided within a few days.

Austria

Austria enters tough-to-implement COVID-19 lockdown without vaccinations

Austria on Monday entered a lockdown for people not vaccinated against the coronavirus, with reinforced police checks to ensure compliance, although city streets appeared busy as ever.

The conservative-led government says nearly two million people in the country, numbering about nine million, are now only allowed to leave their homes for limited reasons such as going to work or shopping for essentials.

It aims to combat a rise in infections fueled by the absolute vaccination rate of only about 65% of the population, to record levels that are among the lowest in Western Europe.

Austria is hardest hit by a fourth wave of infections in Europe, which has prompted governments to consider resuming lockdowns. , Reuters

new book

How monkeys were tracked for covaccine trial: New book by Balaram Bhargava explains

Twenty rhesus macaque monkeys used during trials of Covaxin were found near Nagpur as they moved deep into Maharashtra’s forests after losing their usual urban food sources due to the COVID lockdown in 2020, a new book says. Had gone.

In “Going Viral: Making of Covaccine – The Inside Story”, Dr Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) talks about India’s journey of indigenous vaccine.

The book also touches on the intricacies of science and the challenges faced by Indian scientists during the fight against COVID-19, from development of a strong laboratory network, diagnosis, treatment and serosurvey to new technologies and vaccines.

Study

COVID antibodies found in breast milk of vaccinated, infected mothers: Study

According to a study, mothers who contract the COVID-19 infection and who get vaccinated against the disease produce breast milk with active SARS-CoV-2 antibodies.

However, a recent study published in the JAMA Pediatrics journal does not imply that antibodies to breast milk can provide protection against COVID-19 for nursing babies.

The researchers collected samples from 77 mothers — 47 in the infected group, 30 in the vaccine group — to determine antibody levels in breast milk over time.

They noted that mothers who had immunity produced higher levels of immunoglobulin A (IgA) antibodies against the virus in breast milk, while vaccine-derived immunity produced stronger immunoglobulin G (IgG) antibodies, They said.

Punjab

Spicehealth sets up mobile lab for COVID testing at Amritsar International Airport

SpiceHealth, the healthcare arm of Gurugram-based SpiceJet Group, on Monday announced its entry into Punjab with the setting up of its first mobile laboratory for COVID testing at Amritsar’s Sri Guru Ram Dass Ji International Airport.

The mobile testing laboratory will offer RT-PCR, rapid RT-PCR and antigen testing for all incoming and outgoing passengers from the city, the company said in a release.

This will help ramp up the COVID testing at the airport in Amritsar city, which is one of the most populous cities in the state as well as adjoining districts, the company said in a release. , PTI

National

Active COVID-19 cases in the country lowest in 523 days

India’s Covid tally rose to 3,44,47,536 with 10,229 more people testing positive for coronavirus, while active cases declined to 1,34,096, according to data updated by the Union Health Ministry on Monday. Lowest in 523 days.

Data updated at 8 am showed the death toll reached 4,63,655 after 125 new deaths were reported.

The active COVID-19 caseload has registered a decrease of 1,822 cases in a 24-hour period.

The daily positivity rate was recorded at 1.12%. It is less than 2% since last 42 days.- PTI

Ahmedabad

Genome sequencing: Ahmedabad COVID-19 samples detected with delta, kappa variants

Samples of COVID-19 patients sent for genome sequencing from Gujarat’s Ahmedabad in August and September to a laboratory in Maharashtra’s Pune were found to be infected with both ‘delta’ and ‘kappa’ variants, an official said here on Sunday.

Dr Kanu Patel of the microbiology department of the government-run BJ Medical said that one of the two samples sent to the Pune laboratory in August contained the delta and kappa forms of coronavirus, while a sample sent in September had the delta variant. College here.

“The results of samples of COVID-19 patients sent for genome sequencing to the National Institute of Virology in Pune in October are awaited. No samples have been sent in November so far,” he said. PTI

National

IMA emphasizes on Kovid-19 vaccine for all diabetics

The Indian Medical Association (IMA) on Sunday called for COVID-19 vaccination for all diabetics, including a booster dose, if needed. The association launched a campaign for early detection and reduction of complications of diabetes.

The campaign, launched on the occasion of World Diabetes Day, will run for 10 days and aims to reach one billion people, the IMA said in a release. As part of the campaign, IMA has joined hands with Association of Physicians of India and other organizations.

West Bengal

Bengal seeks to start on-campus classes in a phased manner

Education Minister Bratya Basu on Sunday said that the West Bengal government intends to start physical classes in schools in a phased manner but will not rush it in view of the current COVID-19 situation.

Schools, colleges and universities will open their campuses in a systematic manner from November 16 and higher classes will now resume.

“We plan to start all classes but in a phased manner,” Mr Basu told reporters on the sidelines of an event here. He said, “As of now classes from 9th to 12th standard will be held in schools. Colleges and universities will also start offline classes in a graded manner. Later we will take a decision in the best interest of all considering the current COVID situation,” he said. , PTI

Egypt

Egypt announces clinical trial of homemade COVID-19 vaccine

Egypt’s national research body said on Sunday it would begin clinical trials for a domestically manufactured coronavirus vaccine.

The country’s acting health minister, Khalid Abdel Ghaffar, told reporters at a news conference that he was starting clinical trials of the new vaccine. He said the trial of the vaccine, named ‘COVI VAX’, would start with tens, then hundreds, and eventually thousands of people.

Sunday’s announcement in Cairo was the first sign that researchers there have moved from developing a vaccine and injecting it to people who are test subjects. The World Health Organization has recognized the first Egyptian vaccine as one of hundreds of formulas that are in development worldwide.

The government is trying to encourage more of its population to get vaccinated as the number of cases has risen in recent weeks. From 15 November, all government employees are expected to show proof of vaccination to enter their workplaces.- AP

,